29: Hydroxychloroquine – Potentially toxic, p...

In recent years, there have been a number of exciting new treatments for glaucoma, a sight-threatening condition that is increasing in prevalence as the population ages. These innovations ensure that patients no longer face a binary choice between eye drops and invasive surgery. ...  Show more

The UK government has recently finished consulting on proposals to introduce mandatory eyesight testing for drivers aged 70 and over as part of the licence renewal process. The current vision standards for driving have been in place since the 1930s, and several tragic cases in wh ...  Show more

Dr. Edmund Tsui interviews authors Dr. Muhammad Z. Chauhan and Dr. Krishna S. Kishor on the risk of uveitis among patients starting topical glaucoma therapy. From their Ophthalmology Glaucoma article, "<a href= "https://www.ophthalmologyglaucoma.org/ ...

In this episode, Robert J. Noecker, MD, reviews the role of preservatives, particularly benzalkonium chloride (BAK), in ophthalmic medications. While BAK effectively prevents bacterial growth, its inherent toxicity poses challenges with prolonged use, leading to symptoms associat ...  Show more

Dr. Drew Carey interviews medical student Jawad Muayad and Dr. Sami S. Dahr on the impact of systemic medications, including glucagon-like peptide-1 receptor agonists, fenofibrates, thiazolidinediones, and calcium channel blockers, on the risk of developing diabetic macular edema ...  Show more

CardioNerds (Dr. Amit Goyal) join Dr. Anureet Malhotra, Dr. John Fritzlen, and Dr. Tarun Dalia from the University of Kansas School of Medicine for some of Kansas City’s famous barbeque. They discuss a case of Hydroxychloroquine induced cardiomyopathy. Notes were drafted by Dr. A ...  Show more